Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors

Alvaro Moreira, Carmen Loquai, Claudia Pföhler, +14

European Journal of Cancer

Autoimmune DiseaseImmune Checkpoint InhibitorsImmune RegulationImmunologyImmune Checkpoint Inhibitor +4

Results from an Observational Trial: Digital Epiluminescence Microscopy Follow-Up of Atypical Nevi Increases the Sensitivity and the Chance of Success of Conventional Dermoscopy in Detecting Melanoma

Holger A. Haenssle, Ullrich Krueger, Claudia Vente, +6

Journal of Investigative Dermatology

Dermoscopic ImageDetecting MelanomaSkin CancerMedical ImagingMicroscopy +9

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

Markus V. Heppt, Teresa Amaral, Katharina C. Kähler, +18

Journal for ImmunoTherapy of Cancer

Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection

Lutz Kretschmer, Kai‐Martin Thoms, Sabine Peeters, +3

Melanoma Research

Surgical OncologyMorbid Surgical ProcedureLymph Node ExcisionSurgeryDermatology +14

Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case–control study

Sandra Blankenburg, Inke R. König, Rotraut Moessner, +12

Carcinogenesis

Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter study

Martin Salzmann, Ulrike Leiter, Carmen Loquai, +6

European Journal of Cancer

Tumor BiologyMedicineReal-world DataCell DeathPathology +7

Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression

Kai‐Martin Thoms, Christiane Kuschal, E. Oetjen, +6

Experimental Dermatology

Sentinel lymph node status is the most important prognostic factor for thick (≥ 4 mm) melanomas

Ralf Gutzmer, Imke Satzger, Kai‐Martin Thoms, +5

JDDG Journal der Deutschen Dermatologischen Gesellschaft

Factors Predicting the Risk of In-Transit Recurrence After Sentinel Lymphonodectomy in Patients With Cutaneous Malignant Melanoma

Lutz Kretschmer, Iris Beckmann, Kai‐Martin Thoms, +3

Annals of Surgical Oncology

Cutaneous Malignant MelanomaSurgical OncologyMedicineCancer RecurrenceMelanoma +8

Age as a key factor influencing metastasizing patterns and disease‐specific survival after sentinel lymph node biopsy for cutaneous melanoma

Lutz Kretschmer, Hans Starz, Kai‐Martin Thoms, +9

International Journal of Cancer

Surgical OncologyEpidemiology Of CancerPathologyYounger AgeDermatology +14